BECTON, DICKINSON AND COMPANY

Lobbying for BECTON DICKINSON AND COMPANY

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $1,496,000.00 expenses · posted Jan 15, 2026

Official filing document

Lobbying activity 5

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

Trade (domestic/foreign)

Issues related to medical device supply chain Issues related to international trade

Medicare/Medicaid

Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.